Alvotech to report first nine months financial results on november 15, 2022 and host business update conference call at 8:00 am et on november 16, 2022

Alvotech (nasdaq: alvo), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first nine months of 2022, after u.s. markets close on tuesday, november 15, 2022.
ALVO Ratings Summary
ALVO Quant Ranking